1. Introduction {#s0005}
===============

Hyperandrogenism is a common endocrine disorder among reproductive aged women ([@bb0100]). Excessive concentration of androgen in ovarian follicles may alter oocyte developmental competence that consequently decreases the fertilization rate and embryonic development during in vitro fertilization (IVF) ([@bb0115], [@bb0070], [@bb0120]). Animal studies showed that intrauterine testosterone exposure induced metabolic alterations, including reduced glucose stimulated insulin secretion and impaired glucose tolerance, in offspring not only at early age but also in adulthood ([@bb0005], [@bb0080]). However, the long term health implications of children conceived by women with hyperandrogenism remain largely unknown.

Human epidemiological studies have indicated the inheritance of environment-induced phenotype ([@bb0050]). Offspring of in utero malnutrition are associated with increased prevalence of type 2 diabetes risk ([@bb0095]). Famine experiences in grandfathers increased the risk of obesity and cardiovascular diseases in grandchildren ([@bb0085]). Although the exact mechanism is unclear, these studies indicate that the environmental factors are associated with the inheritance of disease risk in next generations.

Recently, a series of animal studies have revealed that adverse paternal factors increase the susceptibility to adult metabolic diseases in offspring through gametic epigenetic alterations ([@bb0015], [@bb0105], [@bb0130]). Paternal high-fat-diet exposure may program β-cell dysfunction in first-generation (F1) female offspring in rat ([@bb0075]). Intrauterine undernutrition impairs lipid metabolism in second-generation (F2) offspring by transmission of DNA methylation alteration via paternal linage ([@bb0065]). Likewise, paternal prediabetes can be transgenerationally inherited through the male germ line depending on methylation changes in mice ([@bb0125]). A recent study in rodent, using IVF and embryo transfer (IVF-ET) and foster mother, demonstrated that a parental high-fat diet renders offspring more susceptible to developing obesity and diabetes in a sex- and parent of origin-specific mode ([@bb0055]). Two studies showed that maternal diabetes and obesity resulted in altered oocyte methylation patterns of specific genes ([@bb0040], [@bb0045]). Hence, it is very important to investigate whether oocytes, especially human oocytes, from mother with endocrine disorders are associated with increased risks of metabolic disorders in their children, and what mechanisms are involved.

The aim of this study was to investigate whether mothers with pregestational hyperandrogenism could predispose offspring to glucose metabolism disorder through epigenetic oocyte inheritance. Our results demonstrated that children born to mothers with pregestational hyperandrogenism manifested increased serum fasting glucose and insulin levels, and were more prone to prediabetes. High androgen levels significantly upregulated *IGF2*, an imprinting gene, expression in human oocytes. In parallel, study in rats clearly showed that pregestational hyperandrogenism induced diabetic phenotypes and impaired insulin secretion in offspring. Exposure of rat oocytes with high androgen concentration increased the expression level of *Igf2* not only in mothers\' oocytes but also in β-cells of F1 pancreatic islets.

2. Materials & Methods {#s0010}
======================

2.1. Participants and Prospective Cohort Study Design {#s0015}
-----------------------------------------------------

The study was approved by the ethical committee of School of Medicine, Zhejiang University, Hangzhou, China. Total of 1782 women, who registered in Reproductive Center, Women\'s Hospital, School of Medicine, Zhejiang University for IVF between 2005 and 2010, voluntarily participated in this study. All participants provided informed written consents. Their basal hormones including testosterone (TTE), dehydroepiandrosterone (DHEAS) levels were examined at menstrual cycle day-3. Women were excluded if they were not pregnant till December 2010 (n = 355) or withdrew consents (n = 21). Among the remaining 1406 pregnant women, 38 were with ectopic pregnancy, 95 went through miscarriage and 75 women were lost to follow up before delivery. After delivery, 55 women declined child testing. The inclusion criteria for hyperandrogenism group were basal TTE level higher than 2.4 nmol/L and/or basal DHEAS level higher than 8.8 μmol/L. During the follow up period, 27 women without hyperandrogenism were lost to follow up. Finally, 156 children born to women with hyperandrogenism and 1060 children born to women without hyperandrogenism attended our face to face follow up. Twins were handled as 2 separate children. None of the children had significant medical conditions which might affect their development. Children were followed up for 2--7 years after they were born (mean ages about 5 years).

2.2. Anthropometrics and Glycometabolism of Children {#s0020}
----------------------------------------------------

Children were required to attend the hospital at 8 am after an overnight fasting. Blood pressure measurements were performed after 20 min of quiet rest. Prediabetes was diagnosed if fasting glucose was 5.6--6.9 mmol/L. Oral glucose tolerance test (OGTT) was administrated in 132 singleton children born to women without hyperandrogenism and 80 singleton children born to women with hyperandrogenism after taking glucose at a dose of 1.75 g/kg body weight.

2.3. Human Oocytes and Lymphocytes Collection {#s0025}
---------------------------------------------

Human MII oocytes were donated by the patients undergoing IVF/intra-cytoplasmic sperm injection (ICSI) procedure. All patients signed consent forms. Oocytes (n = 10) from women with hyperandrogenism and oocytes (n = 12) from control women were directly used for immunofluorescence analysis. Additional 20 oocytes from control women were cultured with 0 M (n = 10) and 10^− 9^ M (n = 10) DHT for 30 h at 37 °C in a humidified atmosphere of 5% CO~2~ in air. Lymphocytes from children were separated using density gradient and stored at − 80 °C for further experiments.

2.4. Pregestational Hyperandrogenism Rat Model {#s0030}
----------------------------------------------

Rat experiments were approved by the Animal Care and Use Committee, Zhejiang University. Hyperandrogenism female rat model was established using testosterone propionate injection at age of 9 days as previously described ([@bb0030]). At 6 weeks old, serum testosterone/sex hormone-binding globulin (SHBG) levels were examined using ELISA kit (R&D Systems, Minneapolis, MN, USA). Ovarian CYP17a was examined by immunohistochemical analysis (anti-CYP17a antibody, 1:200, Bioss, MA, USA; and CWBIO DAB kit, Guangzhou, China).

Mature oocytes were collected from 6-week-old rats. Meanwhile, hyperandrogenism female rats were mated with normal male rats, and pregnancy was determined by the presence of copulation plug.

2.5. Rat Offspring Glycometabolism and Islet Isolation {#s0035}
------------------------------------------------------

Glucose tolerance tests (GTT) of offspring were performed at 3-week-old and 8-week-old rats (male and female numbers were even in each groups). Offspring pancreatic islets were isolated at embryonic day 20 (E20), 3 weeks and 8 weeks old, respectively, as previously reported ([@bb0025]).

2.6. Quantitative Real Time-PCR and Bisulfite Genomic Sequencing PCR (BSP) {#s0040}
--------------------------------------------------------------------------

Total RNA was extracted from human peripheral lymphocytes and rat islets using RNAiso™ Reagent (TAKARA, Dalian, China), and cDNA was reverse-transcribed using the PrimeScript™ RT Reagent Kit (TAKARA). The methylation status of human *IGF2*, *GRB10* genes and rat *Igf2* gene were analyzed by sequencing of bisulfite-treated DNA using the EpiTect bisulfite kit (Qiagen). The schematic diagrams of CpG sites in human IGF2 and rat Igf2 were shown in Supplementary Fig. 1.

2.7. Immunofluorescence {#s0045}
-----------------------

Human oocytes were incubated with rabbit primary anti-IGF2 antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or rabbit primary anti-DNMT3a antibody (1:200; Santa Cruz Biotechnology) at 4 °C overnight, and rat oocytes were incubated with rabbit primary anti-DNMT3a antibody (1:200; Santa Cruz Biotechnology) under the same condition. Alexa Fluor 594 goat anti-rabbit IgG (1:400; Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 488 goat anti-rabbit IgG secondary antibody (1:400; Invitrogen) were used, respectively.

2.8. Statistical Analysis {#s0050}
-------------------------

Data were analyzed using SPSS 16.0 for Windows (SPSS, Inc., Chicago, USA). We estimated crude and adjusted relative risks (RRs) with 95% confidence intervals using logistic regression. The independent-samples *t*-test was used to evaluate statistical significance between two groups. Chi-square test was used to compare quantitative data between two groups. P value \< 0.05 was considered statistically significant.

3. Results {#s0055}
==========

3.1. Children Born to Mothers with Pregestational Hyperandrogenism Were More Susceptible to Prediabetes {#s0060}
-------------------------------------------------------------------------------------------------------

The flow chart of our prospective cohort study was presented in [Fig. 1](#f0005){ref-type="fig"}. Of 1782 reproductive-aged women detected androgen levels in pregestation, 1406 were pregnant (accumulating pregnancy rate: 78.90%) between 2005 and 2010. Of 1198 women who delivered, 1116 eligible mothers (147 women with hyperandrogenism and 969 normal women) were recruited (93.16%). Information about their 1216 children (1060 from normal mothers and 156 from women with hyperandrogenism) was available. Perinatal data showed that birth weight and gestational weeks were comparable (Supplementary Table 1). Offspring ages at follow-up were 59.85 ± 13.05 and 60.42 ± 12.40 months born to women with and without hyperandrogenism, respectively. As presented in [Table 1](#t0005){ref-type="table"}, there were no significant differences in baseline index of children\'s anthropometry, blood pressures and fasting blood lipid levels. Fasting glucose, insulin and HOMA-IR levels were significantly higher in the children born to women with hyperandrogenism, although the BMI was comparable. There were no significant differences in metabolic phenotypes between male and female (Supplementary Table 2). Furthermore, OGTT demonstrated that both glucose and insulin levels at fasting and 120 min after glucose intake were significantly elevated in children born to women with hyperandrogenism. Importantly, we found that 2.56% (4/156) children born to mothers with hyperandrogenism and 0.66% (7/1060) children born to mothers without hyperandrogenism manifested prediabetes (crude RR = 3.88 (95%CI 1.15--13.20), adjusted RR = 3.98 (95%CI 1.16--13.58), [Table 2](#t0010){ref-type="table"}), indicating that offspring born to mothers with hyperandrogenism was more susceptible to prediabetes.Fig. 1Flow chart of the clinic study and follow-up of the study participants.a, 878 singletons and 182 twins. b, 138 singletons and 18 twins.Fig. 1Table 1Follow-up characteristics of children born to mothers without or with hyperandrogenism.Table 1Without hyperandrogenismWith hyperandrogenismp-ValueNo. of subjects1060156Age (months)59.9 ± 13.160.4 ± 12.5NSBMI (kg/m^2^)15.3 ± 1.115.6 ± 1.6NSBlood pressure (mmHg) Systolic blood pressure98.1 ± 13.998.1 ± 13.9NS Diastolic blood pressure55.8 ± 10.155.7 ± 10.2NSBlood lipids (mmol/L) Triglyceride0.72 ± 0.200.71 ± 0.27NS Cholesterol4.29 ± 0.704.33 ± 0.89NS HDL1.49 ± 0.271.45 ± 0.24NS LDL2.29 ± 0.562.41 ± 0.71NSFasting glucose (mmol/L)4.73 ± 0.434.82 ± 0.43\< 0.05Fasting insulin (μU/mL)3.52 ± 1.624.13 ± 2.69\< 0.01HOMA-IR0.80 ± 0.450.89 ± 0.72\< 0.05OGTT[a](#tf0005){ref-type="table-fn"} Fasting glucose (mmol/L)4.60 ± 0.414.72 ± 0.37\< 0.05 60 min glucose (mmol/L)6.08 ± 0.816.05 ± 0.42NS 120 min glucose (mmol/L)4.85 ± 0.705.13 ± 0.73\< 0.05 Fasting insulin (μU/mL)3.12 ± 1.883.58 ± 1.62\< 0.05 60 min insulin (μU/mL)13.51 ± 7.3815.76 ± 8.67NS 120 min insulin (μU/mL)4.72 ± 4.0910.53 ± 5.25\< 0.01[^2][^3]Table 2Odds ratios of prediabetes in children born to women without and with hyperandrogenism.Table 2PrediabetesWithout hyperandrogenism\
(n, %)With hyperandrogenism\
(n, %)Crude RR\
(95%CI)Adjusted RR[a](#tf0010){ref-type="table-fn"}\
(95%CI)Yes7 (0.66%)4 (2.56%)3.88 (1.15,13.20)3.98 (1.16,13.58)No1053 (99.34%)152 (97.44)11[^4]

3.2. Hyperandrogenism Upregulated IGF2 Expression in Human Oocytes and Offspring Lymphocyte {#s0065}
-------------------------------------------------------------------------------------------

Oocytes from women with hyperandrogenism demonstrated an increased expression level of IGF2 ([Fig. 2](#f0010){ref-type="fig"}A). In vitro experiment verified that treatment of human oocytes with DHT significantly upregulated IGF2 expression ([Fig. 2](#f0010){ref-type="fig"}B) while downregulated DNMT3a expression ([Fig. 2](#f0010){ref-type="fig"}C). Real-time PCR analysis showed that among 9 imprinting genes related to glucose metabolism, IGF2, a maternal imprinting gene, and GRB10, an equal biallelic expressed imprinting gene, levels were significantly upregulated in offspring born to women with hyperandrogenism ([Fig. 2](#f0010){ref-type="fig"}D). We conducted BSP to check the methylation rates of *IGF2* and *GRB10* genes. The overall methylation rate in DMR2 of *IGF2* in offspring born to women with hyperandrogenism was significantly decreased ([Fig. 2](#f0010){ref-type="fig"}E). Meanwhile, the methylation rate in DMR of *GRB10* was also decreased ([Fig. 2](#f0010){ref-type="fig"}F).Fig. 2Imprinting genes in human oocytes (mother) and lymphocytes (offspring). **A:** IGF2 expression in oocytes donated by women with hyperandrogenism (HA, n = 10) or without hyperandrogenism (control, n = 12) was detected by immunofluorescence. **B and C:** Effects of 10^− 9^ M DHT on IGF2 and DNMT3a expression in human oocytes donated by women without hyperandrogenism were examined by immunofluorescence (n = 5 for each group). **D:** Expression of imprinting genes in lymphocyte of offspring conceived by women with (HA, n = 80) or without hyperandrogenism (control, n = 146). **E and F:** Methylation status of IGF2 and GRB10 in lymphocyte of offspring. Methylation status of the IGF2 DMR2 and GRB10 DMR was analyzed by BSP (n = 3 per group). The methylation rates of individual CpG sites within the IGF2 DMR2 and GRB10 DMR were presented as a line graph. \*p \< 0.05, vs. Ctrl, \*\*p \< 0.01, vs. Ctrl, \*\*\*p \< 0.001, vs. Ctrl.Fig. 2

3.3. Pregestational Hyperandrogenism Induced Early-onset Diabetes Due to Impaired Insulin Secretion in Rat Offspring {#s0070}
--------------------------------------------------------------------------------------------------------------------

Female rats with hyperandrogenism (F0) were mated to normal males to obtain offspring (F1) ([Fig. 3](#f0015){ref-type="fig"}A). Hyperandrogenism female founders displayed increased testosterone levels and free androgen index before mating ([Fig. 3](#f0015){ref-type="fig"}B). Ovary immunohistochemistry showed increased expression of CYP17a in theca and granulosa cells, indicating that there were higher androgen levels in follicles (Supplementary Fig. 2). F1 born to hyperandrogenism F0 and normal F0 showed comparable birth weight (Supplementary Fig. 3A) and body weight at 3 and 8 weeks old (Supplementary Fig. 3B), but F1 born to hyperandrogenism F0 showed increased energy and water intakes (Supplementary Fig. 3C and D), and significantly increased fasting glucose level at as early as 3 weeks old ([Fig. 3](#f0015){ref-type="fig"}C, left). In addition, data from GTT showed that offspring of hyperandrogenism at both 3 and 8 weeks old had higher glucose levels ([Fig. 3](#f0015){ref-type="fig"}C and D, middle) and increased under curve area ([Fig. 3](#f0015){ref-type="fig"}C and D, right). Meanwhile, decreased insulin secretion was detected in 3- and 8-week-old offspring born to hyperandrogenism ([Fig. 3](#f0015){ref-type="fig"}E and F), indicating pancreatic islet dysfunction. There were no significant differences in glucose and insulin levels between male and female offspring (Supplementary Table 3).Fig. 3Experimental design and GTT in rat offspring. **A:** Experiment design. Circles designate females and squares designate males. Hyperandrogenism and normal female rats (HA-F0 and Ctrl-F0) were mated with normal female to generate offspring (F1). **B:** Testosterone and Free Androgen Index (FAI) levels in F0 ovarian follicles. **C:** Fasting glucose levels of 3-week-old offspring (left panel), GTT and AUC of 3-week-old offspring (middle and right panel). n = 8 and 22 for control and hyperandrogenism, respectively. **D:** Fasting glucose levels of 8-week-old offspring (left panel), GTT and AUC of 8-week-old offspring (middle and right panel). n = 10 and 16 for control and hyperandrogenic, respectively. **E and F**: Insulin levels of 3- and 8-week-old offspring in GTT. Data are presented as means ± SE. \*p \< 0.05, vs. Ctrl, \*\*p \< 0.01, vs. Ctrl, \*\*\*p \< 0.001, vs. Ctrl.Fig. 3

3.4. Hyperandrogenism-induced IGF2 Hypomethylation in Rat Offspring Pancreatic Islet was Inherited from Oocyte {#s0075}
--------------------------------------------------------------------------------------------------------------

To directly investigate the inheritance of epigenetic marks, we examined four imprinting genes related to glucose metabolism in F0 oocytes and F1 pancreatic islets ([Fig. 4](#f0020){ref-type="fig"}A). Significantly upregulated *Igf2* expression was found in both the F0 oocytes ([Fig. 4](#f0020){ref-type="fig"}B) and F1 pancreatic islets ([Fig. 4](#f0020){ref-type="fig"}C). The methylation patterns of *Igf2* DMR in both F0 oocytes (gametic cells) and F1 embryonic islets (somatic cells) were analyzed. The overall methylation level of *Igf2* gene was significantly decreased in F0 oocytes ([Fig. 4](#f0020){ref-type="fig"}D) as well as in F1 islets ([Fig. 4](#f0020){ref-type="fig"}E) from hyperandrogenism group. In particular, the same signatures of hypomethylation in sites 4, 7 and 9 from both oocytes ([Fig. 4](#f0020){ref-type="fig"}F) and fetal islets ([Fig. 4](#f0020){ref-type="fig"}G) were identified, suggesting that the methylation alteration in offspring islets might be inherited from mother\'s oocytes. On the other hand, immunofluorescence analysis showed that the intensity of DNMT3a in oocytes from hyperandrogenism F0 was significantly higher than that in oocytes from control group ([Fig. 4](#f0020){ref-type="fig"}H).Fig. 4Expression and methylation status of Igf2 in rat oocytes (F0) and pancreatic islets (F1). **A:** Schematic diagram showing transmission of epigenetic marks from germ cells (F0, oocytes) into somatic cells (F1, pancreatic islets cells). **B:** Expression of *Igf2* mRNA in oocytes. **C:** Expression of *Igf2* mRNA in offspring islets (embryonic day 20 (E20), 3 and 8 weeks old). **D and E:** Overall methylation status of *Igf2* in F0 oocytes and F1 pancreatic islets. **F and G:** Methylation status in individual CpG sites of *Igf2* in F0 oocytes and F1 pancreatic islets. Methylation status of the *Igf2* DMR2 was analyzed by bisulfite sequencing (n = 3 per group). The methylation rates of individual CpG sites within the *Igf2* DMR2 are presented as a line graph. **H:** Expression of *Dnmt3a* in rat oocyte treated with in-vitro DHT (10^− 9^ M) by immunofluorescence. Data are presented as means ± SE. \*p \< 0.05, vs. Ctrl, \*\*p \< 0.01, vs. Ctrl, \*\*\*p \< 0.001, vs. Ctrl.Fig. 4

4. Discussion {#s0080}
=============

In this clinical cohort study, we found that hyperandrogenism in mothers might increase the risks of abnormal glucose metabolism in their children. According to the Barker\'s Theory "fetal origins of adult diseases", adverse intrauterine environment during pregnancy can predispose offspring to diabetes, cardiovascular diseases and obesity in later life. Recently, animal studies demonstrated that high-fat-diet exposure in fathers ([@bb0075]) or mothers ([@bb0055]) before conception might also induce metabolic disorders in their offspring via gametic epigenetic alterations. The present study is an investigation in humans to examine whether hyperandrogenism in mothers may induce the alteration of glucose metabolism in their offspring via epigenetic inheritance from mother\'s oocyte to offspring\'s somatic cells.

Hyperandrogenemia is a common disorder in women of reproductive age, especially in subfertile women ([@bb0100]). In this investigation, 147 women manifesting hyperandrogenism among the 1116 women were recruited (13.17%). Some clinic study indicated that in vivo fertilization rates women with hyperandrogenism were normal ([@bb0035]) meanwhile some showed that they might have poor oocyte quality leading to decreased fertilization and implantation rates ([@bb0100], [@bb0070], [@bb0120]). The long term health of their children is well worth studying. Our previous work reported that maternal excessive estrogen exposure before pregnancy might predispose offspring to cardiovascular dysfunction ([@bb0140]). Here, we provide evidence that pregestational hyperandrogenism may induce alteration of glucose metabolism in offspring. We found that children born to mothers with pregestational hyperandrogenism had the increased fasting glucose, insulin and HOMA-IR levels. Importantly, they were more susceptible to prediabetes at as early as 5 years old. The risk for prediabetes was still significant after adjusting for gestational complications, suggesting a relationship between pregestational hyperandrogenism in mothers and prediabetes in their children.

In the present study, we took advantage of the IVF procedure to focus on the imprinting alteration in oocyte before fertilization. Analysis in human showed that expression of *IGF2*, an acknowledged maternal imprinted gene responsible for β-cell function, was increased in oocytes from patients with hyperandrogenism. In vitro DHT treatment also increased *IGF2* expression in human oocytes. In female germ line, methylation establishment of imprinting genes is catalyzed by DNA methyltransferase (DNMT) 3a. So we also evaluated the effect of high androgen on DNMT3a expression. We found that in vitro DHT treatment decreased DNMT3a expression in human oocytes. It has been reported that disturbance before conception was associated with widespread epigenetic modifications in offspring even though the phenotype was normal ([@bb0010]). In agreement with this research, our data showed that the upregulation of IGF2 was also detected in children\'s somatic cells (lymphocytes) as found in oocytes, which might be due to hypomethylation in *IGF2* DMR2. These results suggested that hyperandrogenism-induced imprinting marks in female germline might be passed down to the next generation. Because of the limitation of human tissue samples collected, we don\'t know whether the epigenetic alterations which we detected in lymphocytes might occur in other somatic cells including pancreatic islet cells. Further study is needed to clarify it.

In order to clarify the epigenetic inheritance from oocyte to pancreatic islets, we established a rat model. We found that offspring born to pregestational hyperandrogenism rat developed diabetes at young age, which was probably attributed to impaired pancreatic islet function because of decreased response of insulin secretion to glucose stimulation. This result was similar to a previous study in mice, in which male offspring born to excessive testosterone showed lower fasting and fed insulin levels ([@bb0080]). Moreover, the decreased insulin levels to glucose stimulation suggest that the disruption in pancreatic islets might be more obvious in the rat offspring of hyperandrogenism mothers than human being.

In mice, when fertilized oocytes of diabetic mothers were transferred to non-diabetic pseudo-pregnant recipients, specific phenotypes such as growth retardation and congenital malformation were observed in offspring ([@bb0135]). Another report showed that ovarian stimulation alone impaired fetal growth in IVF mice ([@bb0020]). These studies suggested that the health problem in offspring might be initiated from oocyte. In this study, we collected the oocytes from F0 rats and pancreatic islets from F1 offspring to directly investigate the intergenerational transmission of gametic epigenetic changes. Our data showed that pregestational high androgen upregulated *Igf2* mRNA level, meanwhile downregulated *Igf2* DMR2 methylation rate in the pancreatic islets of offspring from prenatal period to adulthood. Similarly to our results, BPA (an endocrine disruptor which can bind to androgen receptor) induced β-cell dysfunction in adult offspring was attributed to the transmission of methylation changes in *igf2* genes from parents ([@bb0060]).

It is known that environmental changes can alter the overall methylation patterns in gametes, and a number of these methylation are found to be heritable ([@bb0090], [@bb0110]). In the present study, we found that the same *Igf2* epigenetic signature, the hypomethylation in CpG sites 4, 7 and 9, identified in offspring pancreatic islets was already present in mature oocyte from their mothers. The upregulation and hypomethylation of *Igf2* was present in pancreatic islets of F1 fetuses before born (E20), and this happened before the postnatal epigenetic modification. These results suggest that mothers with hyperandrogenism may induce the intergenerational inheritance of epigenetic alteration via oocytes. Our previous study reported that gestational diabetes predisposed F2 offspring to diabetes, and the transmission of *Igf2* methylation alteration via F1 sperm could be an epigenetic mechanism ([@bb0030]). Here, we provide an evidence for intergenerational transmission of epigenetic alteration via oocyte.

Taken together, this study is the evidence that maternal hyperandrogenism, a common endocrine disorder in reproductive aged women, may increase the risks of glucose metabolism disorder and prediabetes in their children. Data from human and hyperandrogenism rat model suggest that this glucose metabolism disorder may be mediated by DNA methylation modifications, and the epigenetic modification induced by hyperandrogenism may be transmitted from oocytes of mothers to somatic cells of offspring. So intergenerational inheritance of epigenetic alteration should be regarded important in determining development of diabetes in the future.
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Supplementary Fig. 1. The schematic diagrams of CpG sites in human IGF2 and rat Igf2.Supplementary Fig. 2. Expression of CYP17a by immunohistochemistry in rat ovary. Scale bar, 100μm.Supplementary Fig. 3. Phenotype in rat offspring. **A:** Birth weight of F1. **B:** Body weight of F1 at 3-week and 8-week old. **C and D:** Daily energy and water intake of F1 at 3- and 8-week old. Data are presented as means ± SE (n = 10 for both groups). \*p \< 0.05, vs. Ctrl, \*\*\*p \< 0.001, vs. Ctrl.Image 1Supplementary tables.Image 2

This work is supported by the Natural Science Foundation of China (No. 31471405 and 81490742 to H.F.H., No. 81270708 and 31671569 to J.Z.S., and No. 81501340 to L.X.H), the National Basic Research Program of China (2013CB967404 to H.F.H.), the NSFC-CIHR Joint Health Research Program (No. 8161101434 to H.F.H., No. 81361128007 to J.Z.S.), Key project of the Shanghai Committee of Science and Technology (No. 14DJ1400100 to H.F.H.).

Supplementary data to this article can be found online at <http://dx.doi.org/10.1016/j.ebiom.2017.01.011>.

[^1]: These authors contributed equally to this study.

[^2]: Data = mean ± SD, P values were calculated by *t*-test.

[^3]: n = 132 and 80 for singleton born to mother without and with hyperandrogenism, respectively.

[^4]: Adjusted for children\'s age, BMI, maternal preeclampsia and gestational diabetes.
